概括
移植脏的接受者可能会患上类固醇诱导型糖尿病 (SD). HLA-A28抗原显著增加SD风险,特别是在黑人成年人中,但SD不会影响移植的存活率.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 免疫遗传学 免疫遗传学
- 内分泌学 在内分泌学.
背景情况:
- 手术后的类固醇诱导糖尿病 (SD) 是对移植患者的一个担忧.
- 了解SD的风险因素对于患者管理至关重要.
研究的目的:
- 调查非糖尿病成年移植患者中类固醇诱导糖尿病的发生率和危险因素.
- 确定HLA抗原与SD发展之间的关联.
主要方法:
- 从1971年7月到1977年3月,对286名非糖尿病成年移植患者进行了前性观察.
- 分析患者数据,分析类固醇诱导糖尿病的发展以及与各种因素的相关性,包括HLA类型和人口统计数据.
- 统计分析以确定重要的关联.
主要成果:
- 类固醇诱导的糖尿病发生在10.8%的接受者身上.
- 在HLA-A28抗原和SD之间发现了显著的关联.
- HLA-A28在黑人接受者中更为普遍,在这个群体中占SD发病率较高的原因.
- 年龄也与SD有关,但HLA-A28即使经过年龄校正后仍然显著.
- 没有发现与其他HLA类型 (BB, Bw 15),性别,供体来源,排斥治疗或皮质类固醇剂量有显著关联.
- 类固醇诱导的糖尿病并没有对移植或患者的存活产生不利影响.
结论:
- 在移植接受者中,HLA-A28是类固醇诱导糖尿病的重要危险因素.
- 黑人成年人中SD的较高发病率部分是由HLA-A28.8的频率增加所解释的.
- 类固醇诱导的糖尿病不会对移植患者的长期结果产生负面影响.
相关概念视频
Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Tissue Transplantation
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Kidney Transplant I: Introduction
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Kidney Transplant II: Surgical Procedure
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Kidney Transplant III: Nursing Management
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...


